on Catheter Precision, Inc
Catheter Precision Highlights Non-Invasive Cardiac Treatment Using VIVO
Catheter Precision, Inc., a medical device company, announced a new clinical publication in HeartRhythm Case Reports about a novel procedure using stereotactic radioablation (STAR) for heart arrhythmia. This technique uses external photon beams to target problematic heart areas. The procedure highlights the importance of pre-procedural information, where VIVO provided more precise locations compared to traditional methods. This technology was crucial in the successful treatment of a patient, who remained asymptomatic four months post-procedure.
David Jenkins, CEO, emphasized the potential of combining traditional ECGs with 3D imaging and VIVO technology for patient-specific solutions. VIVO's role in pre-procedural planning is highlighted as essential for potentially broader future use.
R. H.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Catheter Precision, Inc news